Psychotropic drugs in Nepal: perceptions on use and supply chain management
- PMID: 29368618
- PMCID: PMC5784600
- DOI: 10.1186/s12992-018-0322-4
Psychotropic drugs in Nepal: perceptions on use and supply chain management
Abstract
Background: Psychotropic drugs play an important role in the treatment of mental, neurological and substance use disorders. Despite the advancement of the use of psycho-pharmaceuticals in the developed countries, the psychotropic drug production and supply chain management in low- and middle- income countries are still poorly developed. This study aims to explore the perceptions of stakeholders involved in all stages of the psychotropic drug supply chain about the need, quality, availability and effectiveness of psychotropic drugs, as well as barriers to their supply chain management. The study was conducted among 65 respondents from the Kathmandu, Chitwan and Pyuthan districts, grouped into four categories: producers, promoters and distributors (N = 22), policy makers and government actors (N = 8), service providers (N = 21) and service users/family members (N = 14).
Results: The respondents reported that psychotropic drugs, despite having side effects, are 1) needed, 2) available in major regional centers and 3) are effective for treating mental health problems. The stigma associated with mental illness, however, forces patients and family members to hide their use of psychotropic drugs. The study found that the process of psychotropic drug supply chain management is similar to other general drugs, with the exceptions of strict pre-approval process, quantity restriction (for production and import), and mandatory record keeping. Despite these regulatory provisions, respondents believed that the misuse of psychotropic drugs is widespread and companies are providing incentives to prescribers and retailers to retain their brand in the market.
Conclusions: The production and supply chain management of psychotropic drugs is influenced by the vested interests of pharmaceutical companies, prescribers and pharmacists. In the context of the government of Nepal's policy of integrating mental health into primary health care and increased consumption of psychotropic drugs in Nepal, there is a need for massive education and awareness as well as strict monitoring and supervision to avoid the misuse of psychotropic drugs.
Keywords: Mental health; Nepal; Psychotropic drugs; Supply chain management.
Conflict of interest statement
Ethics approval and consent to participate
Ethical approval for the study was obtained from the Nepal Health Research Council (NHRC); registration number 88/2013. Verbal consent was taken from the institutional heads and individual respondents. All participants were informed about their right to refuse participation in the study or not to answer any specific questions. Anonymity of all individual participants and institutions associated with them was maintained by removing any personal or institutional identifiers.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
Mental health and psychosocial support services in primary health care in Nepal: perceived facilitating factors, barriers and strategies for improvement.BMC Psychiatry. 2020 Feb 13;20(1):64. doi: 10.1186/s12888-020-2476-x. BMC Psychiatry. 2020. PMID: 32054462 Free PMC article.
-
[The supply and use of psychotropic drugs in Psychosocial Care Centers in Southern Brazil].Rev Esc Enferm USP. 2011 Dec;45(6):1481-7. doi: 10.1590/s0080-62342011000600029. Rev Esc Enferm USP. 2011. PMID: 22241210 Portuguese.
-
Perception of service users and their caregivers on primary care-based mental health services: a qualitative study in Nepal.BMC Fam Pract. 2020 Sep 28;21(1):202. doi: 10.1186/s12875-020-01266-y. BMC Fam Pract. 2020. PMID: 32988367 Free PMC article.
-
Pediatric psychotropic medication initiation and adherence: a literature review based on social exchange theory.J Child Adolesc Psychiatr Nurs. 2010 Aug;23(3):151-72. doi: 10.1111/j.1744-6171.2010.00237.x. J Child Adolesc Psychiatr Nurs. 2010. PMID: 20796098 Review.
-
Do DSM classifications help or hinder drug development? .Dialogues Clin Neurosci. 2020 Mar;22(1):73-79. doi: 10.31887/DCNS.2020.22.1/mdavidson. Dialogues Clin Neurosci. 2020. PMID: 32699507 Free PMC article. Review.
Cited by
-
Treatment Preferences for Pharmacological versus Psychological Interventions among Primary Care Providers in Nepal: Mixed Methods Analysis of a Pilot Cluster Randomized Controlled Trial.Int J Environ Res Public Health. 2022 Feb 14;19(4):2149. doi: 10.3390/ijerph19042149. Int J Environ Res Public Health. 2022. PMID: 35206331 Free PMC article. Clinical Trial.
-
Stigma against mental health disorders in Nepal conceptualised with a 'what matters most' framework: a scoping review.Epidemiol Psychiatr Sci. 2022 Jan 28;31:e11. doi: 10.1017/S2045796021000809. Epidemiol Psychiatr Sci. 2022. PMID: 35086602 Free PMC article. Review.
-
A qualitative study to understand drivers of psychoactive substance use among Nepalese youth.PLoS One. 2021 Nov 5;16(11):e0259021. doi: 10.1371/journal.pone.0259021. eCollection 2021. PLoS One. 2021. PMID: 34739508 Free PMC article.
-
Mental health and psychosocial support services in primary health care in Nepal: perceived facilitating factors, barriers and strategies for improvement.BMC Psychiatry. 2020 Feb 13;20(1):64. doi: 10.1186/s12888-020-2476-x. BMC Psychiatry. 2020. PMID: 32054462 Free PMC article.
-
Effective methods for knowledge transfer to strengthen mental health systems in low- and middle-income countries.BJPsych Open. 2019 Aug 6;5(5):e72. doi: 10.1192/bjo.2019.50. BJPsych Open. 2019. PMID: 31530323 Free PMC article.
References
-
- Eaton J. Ensuring access to psychotropic medication in sub-Saharan Africa. African Journal of Psychiatry. 2008;113:179–181. - PubMed
-
- McBain R, Norton DJ, Morris J, Yasamy MT, Betancourt TS. The role of health systems factors in facilitating access to psychotropic medicines: a cross-sectional analysis of the WHO-AIMS in 63 low-and middle-income countries. PLoS Med. 2012;91:e1001166. doi: 10.1371/journal.pmed.1001166. - DOI - PMC - PubMed
-
- WHO . Improving access and use of psychotropic medicines. 2005.
-
- WHO . Mental Health Gap Action Programme: Scaling up Care for Mental, Neurological and Substance Use Disorder. Geneva: World Health Organization (WHO); 2008. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources